# Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients

> **NCT00633373** · — · NO_LONGER_AVAILABLE · sponsor: **APT Pharmaceuticals, Inc.**

## Conditions studied

- Lung Transplant

## Interventions

- **DRUG:** Cyclosporine Inhalation Solution

## Key facts

- **NCT ID:** NCT00633373
- **Lead sponsor:** APT Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633373, "Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00633373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*